PolyVascular Awarded $3 Million NIH SBIR Phase IIb Grant to Advance Polymer-Based Pediatric Heart Valve Toward Clinical Trials 

by Katie Bales | Apr 24, 2025 | Uncategorized

Houston, TX — April 24, 2025 — PolyVascular, a pioneering medical device company developing the first polymer-based transcatheter pulmonary valve designed specifically for young children, announced today that it has been awarded a $3 million Small Business Innovation...

PolyVascular to Present Groundbreaking Preclinical Study at CRF’s TCT 2024 Conference

by Katie Bales | Oct 1, 2024 | Uncategorized

PolyVascular, a pioneering medtech company focused on developing innovative transcatheter valve solutions for children with congenital heart disease, is proud to announce its acceptance to present at the prestigious Transcatheter Cardiovascular Therapeutics (TCT) 2024...

PolyVascular Presents Latest Preclinical In Vivo Study at 2024 Annual PICS Symposium in San Diego, CA.

by Katie Bales | Sep 5, 2024 | Uncategorized

PolyVascular’s Co-Founder, Dr. Henri Justino, and Engineering Manager, Kelly McKinzey, presented the latest findings from PolyVascular’s preclinical animal study at the 2024 Annual PICS Symposium. The presentation, titled “In Vivo Chronic Performance of a...

PolyVascular Welcomes Steven Girouard, PhD to its Board of Directors

by Katie Bales | Jun 1, 2024 | Uncategorized

PolyVascular, a pioneering company focused on developing the world’s first polymeric, non-surgical pulmonary valve for pediatric patients, is excited to announce that Steven Girouard, PhD, an accomplished medical device executive and consultant, has joined its Board...